CING

Peter J. Werth

Known title: DirectorCIK: 0001883257

Peter J. Werth's purchase track record

How the stock did after each of Peter J. Werth's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.

Purchases measured
5
of 5 since March 17, 2022
Stock higher 6 months later
0%
3 months: 20%
Median 6-month return
-22.4%
3 months: -31.6%
Beat the S&P 500
0%
median -10.8% vs. index
PurchaseStockAmount3 months6 months
2/6/2026CING$98K-31.6%-30.6%
8/11/2023CING$1.00M-42.7%-89.1%
12/13/2022CING$28K+3.0%-1.0%
9/6/2022CING$113K-42.6%-6.5%
3/17/2022CING$48K-26.4%-22.4%

Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 13, 2026

CING noted among health-care stocks with pre-market movement. CING was included in a Benzinga list of twelve health-care stocks that showed activity in the pre-market session on Tuesday. The mention suggests some early-day interest in the stock. The shares are currently near a support level of $5.03 and the RSI of 42.2 indicates modest momentum.

this person other insiders at CING

Transaction History

CING▲ Buy$98K
CING▲ Buy$684
CING▲ Buy$69
CING▲ Buy$1.0M
CING▲ Buy$28K
CING▲ Buy$113K
CING▲ Buy$48K
CING▲ Buy—

We use analytics to understand how market-wall is used. No personal data is sold.